Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A Randomized, Double-Blind, Phase 3 Equivalence Trial Comparing the Etanercept Biosimilar, HD203, with Etanercept (Enbrel®), in Combination with Methortrexate (MTX) in Patients with Rheumatoid Arthritis (RA)
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 배상철 | - |
| dc.date.accessioned | 2021-08-03T08:34:08Z | - |
| dc.date.available | 2021-08-03T08:34:08Z | - |
| dc.date.issued | 2014-11-15 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/41924 | - |
| dc.title | A Randomized, Double-Blind, Phase 3 Equivalence Trial Comparing the Etanercept Biosimilar, HD203, with Etanercept (Enbrel®), in Combination with Methortrexate (MTX) in Patients with Rheumatoid Arthritis (RA) | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | The 78th ACR meeting | - |
| dc.citation.conferencePlace | Boston, MA | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.